Video

CAR-T Cell Therapy: It's Astonishing

Author(s):

Jane N. Winter, M.D.

The time has finally come when researchers have found a way to harness the immune system and use it to fight blood cancers.

Jane N. Winter, M.D., professor of medicine (hematology and oncology) at Northwestern University Feinberg School of Medicine, discusses the excitement surrounding CAR-T cell therapy for the treatment of blood cancers.

Winter is excited that, after generations, researchers have finally harnessed the immune system to treat hematologic malignancies. "When it works, it is astonishing," she said.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help prevent esophageal cancer.
A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.
Image of Dr. Tiziano Barbui
Image of Dr. Merrell
Image of Dr. Evens.
Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer.
Image of Dr. D'sa
Image of doctor.
Image of Dr. Deville.
Image of carly.
Related Content
The phase 1/2 STARLIGHT-1 trial evaluating EB103 has dosed the first patient with advanced B-cell NHL: © stock.adobe.com.
May 30th 2025

First Patient Treated in Second Cohort of STARLIGHT-1 B-Cell NHL Trial

Ryan Scott
The phase 1/2 STARLIGHT-1 trial has dosed the first patient in the second cohort of the study evaluating EB103 in advanced B-cell non-Hodgkin’s lymphomas.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of blood cells.
May 23rd 2025

Breaking Down Treatment Variables in AYA Patients With Cancer

Ryan Scott
Dr. Andrew M. Evens discussed the importance of differentiating AYA cancers from other age groups, specifically focusing on lymphoma care.
CURE Cancer Horizons podcast logo
January 29th 2024

Prostate Cancer Headlines, CAR-T Warnings and Laughter Therapy

Alex Biese Brielle Benyon
CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.
Image of blood cells.
May 21st 2025

FDA’s ODAC Casts Votes on the Use of Certain Treatment Options in Cancer Care

Ryan Scott
The FDA'S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma patient populations, respectively.
Image of hands.
May 21st 2025

Sixteen Years With Leukemia Taught Me to Savor Life

Michelle Lawrence
I’ve lived with large granular lymphocytic leukemia for 16 years and have learned to spend my energy wisely, embrace palliative care and choose joy over anger.